AAIC 2025 Abstract
Quantitative Systems Pharmacology Analysis of Hippocampal Volume Trajectory by APOE Genotype and Neuroprotective Effects of Valiltramiprosate/ALZ‐801 in Early AD
Computational studyInterventions
Abstract
Background: Valiltramiprosate is an oral, small‐molecule inhibitor of β‐amyloid oligomer formation in late‐stage development as a disease‐modifying therapy for AD.
